Hydroxytyrosol (HT), a polyphenol
derived from olive oil, was examined
against dextran sulfate sodium (DSS)-induced colitis to study its
potential in preventing colitis and the underlying mechanisms involved.
The low dose and high dose of HT used in mice were 10 and 50 mg/kg,
respectively. Research findings have shown that HT is effective in
preventing colitis by alleviating the signs of colitis. HT intervention
significantly reduces colitis markers such as myeloperoxidase (MPO)
and proinflammatory cytokine (IL-6, IL-1β, and TNF-α).
Also, mice treated with a high dose of HT showed increased secretion
of antioxidant enzymes (heme oxygenase-1 (HO) and anti-inflammatory
cytokine (IL-10) by 2.32- and 2.28-fold, respectively, in comparison
to the DSS-treated group. Modulation effects of HT on the antioxidant
signal pathway (NRF2) and the inflammatory pathway (NF-κB) were
confirmed. Meanwhile, HT promoted the regeneration of the intestinal
barrier and maintained intestinal functional homeostasis by boosting
the regeneration of goblet cells and the expression of mucin protein
(Muc2) and tight junction (TJ) proteins (claudin-1, occludin, and
Zonula Occludens-1). Moreover, HT intervention obviously transformed
the gut microbiota, leading to a lower abundance of inflammation-related
microbes (e.g., Bacteroidaceae and Desulfovibrionaceae) and a higher
level of short-chain fatty acids (SCFAs) producing bacteria (e.g.,
Lachnospiraceae, Muribaculaceae, ASF356, and Colidextribacter). Scientific
evidence for the beneficial effect of the “Mediterranean diet”
(MD) on intestinal health was achieved by elucidating the alleviation
mechanism of hydroxytyrosol on colitis.